Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7906]

Family dynamics: Molecules from the same family have different effects in cancer prognosis

Family dynamics: Molecules from the same family have different effects in cancer prognosis

Study shows new drug effective in overcoming ibrutinib resistance in mantle cell lymphoma

Study shows new drug effective in overcoming ibrutinib resistance in mantle cell lymphoma

How genomics profiling can help identify the best treatment for bladder cancer

How genomics profiling can help identify the best treatment for bladder cancer

New treatment could become first ever targeted therapy designed for ‘untreatable’ childhood brain cancer

New treatment could become first ever targeted therapy designed for ‘untreatable’ childhood brain cancer

New drug effective in overcoming ibrutinib resistance in mantle cell lymphoma

New drug effective in overcoming ibrutinib resistance in mantle cell lymphoma

Global study predicts more than 50% rise in chemotherapy demand by 2040

Global study predicts more than 50% rise in chemotherapy demand by 2040

$Acalabrutinib increases progression-free survival relapsed or refractory chronic lymphocytic leukaemia$

Acalabrutinib increases progression-free survival relapsed or refractory chronic lymphocytic leukaemia

A new approach to targeting tumours and tracking their spread

A new approach to targeting tumours and tracking their spread

Untangling a cancer signalling network suggests new roadmap to tumour control

Untangling a cancer signalling network suggests new roadmap to tumour control

FDA approves ivosidenib as first-line treatment for AML with IDH1 mutation

FDA approves ivosidenib as first-line treatment for AML with IDH1 mutation

More from ecancer